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ARTICLE
TEX264 coordinates p97- and SPRTN-mediated
resolution of topoisomerase 1-DNA adducts
John Fielden1,7, Katherine Wiseman1,7, Ignacio Torrecilla 1, Shudong Li1, Samuel Hume 1, Shih-Chieh Chiang2,
Annamaria Ruggiano1, Abhay Narayan Singh1, Raimundo Freire 3,4,5, Sylvana Hassanieh1, Enric Domingo 1,
Iolanda Vendrell1,6, Roman Fischer 6, Benedikt M. Kessler 6, Timothy S. Maughan1,
Sherif F. El-Khamisy 2 & Kristijan Ramadan 1✉
Eukaryotic topoisomerase 1 (TOP1) regulates DNA topology to ensure efﬁcient DNA repli-
cation and transcription. TOP1 is also a major driver of endogenous genome instability,
particularly when its catalytic intermediate—a covalent TOP1-DNA adduct known as a TOP1
cleavage complex (TOP1cc)—is stabilised. TOP1ccs are highly cytotoxic and a failure to
resolve them underlies the pathology of neurological disorders but is also exploited in cancer
therapy where TOP1ccs are the target of widely used frontline anti-cancer drugs. A critical
enzyme for TOP1cc resolution is the tyrosyl-DNA phosphodiesterase (TDP1), which hydro-
lyses the bond that links a tyrosine in the active site of TOP1 to a 3’ phosphate group on a
single-stranded (ss)DNA break. However, TDP1 can only process small peptide fragments
from ssDNA ends, raising the question of how the ~90 kDa TOP1 protein is processed
upstream of TDP1. Here we ﬁnd that TEX264 fulﬁls this role by forming a complex with the
p97 ATPase and the SPRTN metalloprotease. We show that TEX264 recognises both
unmodiﬁed and SUMO1-modifed TOP1 and initiates TOP1cc repair by recruiting p97 and
SPRTN. TEX264 localises to the nuclear periphery, associates with DNA replication forks, and
counteracts TOP1ccs during DNA replication. Altogether, our study elucidates the existence
of a specialised repair complex required for upstream proteolysis of TOP1ccs and their
subsequent resolution.
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opoisomerase 1 (TOP1) resolves DNA topological stress
accumulated during DNA replication and transcription. As
part of its catalytic cycle, TOP1 forms an intermediate that
is covalently bound to DNA, known as a TOP1 cleavage complex
(TOP1cc). TOP1ccs are usually transient but can become trapped
if TOP1 cleaves near a DNA alteration or is exposed to TOP1
poisons. Due to their bulky structure, TOP1ccs hinder the pro-
gression of DNA replication and transcription, and are therefore
highly cytotoxic1–3.
Endogenous TOP1ccs pose a constant threat to genome sta-
bility, as illustrated by the numerous neurodegenerative diseases
associated with defective TOP1cc repair2–8. The cytotoxicity of
TOP1ccs is also exploited in cancer therapy by the widely used
class of anti-cancer drugs, known as camptothecins (CPT), which
stabilise TOP1ccs by binding the TOP1–DNA interface.
CPT derivatives are routinely used to treat ovarian, colon, and
lung cancers but resistance is common, underscoring the need to
identify molecular biomarkers and determinants of resistance to
improve patient stratiﬁcation and outcomes9.
A key enzyme in TOP1cc repair is TDP1, a phosphodiesterase
that directly hydrolyses the phosphotyrosyl bond that covalently
links TOP1 to the 3′ end of an ssDNA break10. This step is
necessary to allow re-ligation of the broken DNA strand and
ensure genome stability. Mutations in TDP1 give rise to the
neurodegenerative disease, SCAN12,4,5. However, TDP1 alone
cannot resolve TOP1ccs since its substrate bond is protected
within the bulky TOP1cc structure and is therefore inaccessible to
the TDP1 active site10. TDP1 is unable to resolve full-length,
recombinant TOP1ccs in vitro, however, its activity is enabled if
the TOP1ccs are heat-denatured or proteolytically digested11–15.
This raises the question of how TOP1cc processing upstream of
TDP1 occurs in vivo. A deeper understanding of this process
could unveil mechanisms of clinical resistance to TOP1 poisons
and potential targets of therapeutic intervention.
The proteasome and the metalloproteases SPRTN (in
metazoans) and Wss1 (in yeast) are thought to digest the protein
component of TOP1ccs16–19. In humans, mutations in SPRTN
that impair its proteolytic activity cause Ruijs–Aalfs syndrome
(RJALS), which is characterised by hepatocellular carcinoma and
premature ageing20. SPRTN-deﬁcient human cells accumulate
endogenous TOP1ccs and are sensitive to TOP1cc-inducing
agents19. SPRTN hypomorphic mice accumulate TOP1ccs from
an early age, particularly in the liver, and ultimately develop liver
tumours18. This suggests that SPRTN plays a critical role in
processing TOP1ccs.
Both the proteasome and SPRTN are highly pleiotropic and
preferentially cleave pre-unfolded substrates and/or unstructured
protein regions19,21,22. While the proteasome degrades ubiquiti-
nated proteins, it is unclear how SPRTN recognises and processes
its substrates, which vary substantially in size and structure16,19,23.
Altogether, this implies that other factors must exist to confer
speciﬁcity to, and pre-process, TOP1ccs to enable their proteolytic
digestion.
Both Wss1 and SPRTN have motifs that enable them to bind
the ATPase p97 (also called VCP in mammals and Cdc48 in
yeast)16,17,24. Cdc48 is known to counteract TOP1cc accumula-
tion, however, the mechanistic basis for how it achieves this is not
well deﬁned16,17,25. Here, we demonstrate that p97 is a key player
in TOP1cc repair in human cells. We identify the gyrase
inhibitory-like protein, TEX264, as a p97 cofactor that recruits
p97 to TOP1ccs. TEX264 recognises both unmodiﬁed and
SUMO1-modiﬁed TOP1 and promotes p97- and SPRTN-
dependent TOP1cc repair. TEX264 localises to the nuclear per-
iphery, associates with DNA replication forks, and promotes
TOP1cc repair during DNA replication. Cells deﬁcient in TEX264
accumulate endogenous TOP1ccs, are sensitive to clinically
relevant doses of TOP1 poisons, and exhibit DNA replication
stress. Our data suggest that p97 and TEX264 enable the repair
of TOP1ccs by facilitating their proteolysis via SPRTN upstream
of TDP1. This discovery is important for preserving genome
stability from endogenous TOP1ccs and could be relevant for
clinical resistance to TOP1 poisons.
Results
The ATPase p97 promotes TOP1cc repair. As TOP1ccs are
common endogenous DNA lesions, we reasoned that factors that
promote their repair should interact with the TOP1 protein even
in the absence of TOP1 poisons1,26. To identify modulators of
TOP1cc repair, we isolated chromatin from YFP-TOP1-expressing
human embryonic kidney (HEK) 293 cells and subjected YFP
immunoprecipitates to liquid chromatography–tandem mass
spectrometry (LC–MS/MS; Source Data). This analysis identiﬁed
the ATPase p97 as an abundant interacting partner of TOP1 on
chromatin, which we conﬁrmed by immunoblotting (Supple-
mentary Fig. 1A). By using energy generated from ATP hydrolysis,
p97 remodels its substrates and extracts them from macro-
molecular structures such as chromatin27–33. Given this known
role of p97, and since Cdc48 has been implicated in TOP1cc
repair, we investigated whether p97 contributes to TOP1cc pro-
cessing in human cells.
To assess if p97 counteracts TOP1cc accumulation in
unchallenged conditions, we employed a modiﬁed version of
the recently described rapid approach to DNA adduct recovery
(RADAR) assay to analyse the abundance of proteins covalently
attached to DNA34. By lysing cells in chaotropic salts (6 M
guanidium isothiocyanate), detergents (4% Triton X-100 and 1%
N-lauroylsarcosine), and a reducing agent (1% DTT), all
molecular interactions, other than covalent interactions, are
disrupted. Depletion of p97 in HEK293 cells with either of two
different siRNA sequences resulted in substantial TOP1cc
accumulation, to a similar extent as a short treatment with
1 µM CPT (Fig. 1a–c). In co-immunoprecipitation experiments,
we found that TOP1 bound ~3-fold more strongly to a substrate-
trapping, ATPase-defective p97 variant (E578Q; EQ) than to
wild-type p97 (Fig. 1d). This suggested that the TOP1 protein is
subject to p97’s ATPase activity.
To test if p97 ATPase activity contributes to TOP1cc repair, we
treated human retinal pigmented epithelial (RPE-1) cells with CB-
5083, a potent, selective inhibitor of p97 ATPase activity, and
visualised TOP1cc foci formation by immunoﬂuorescence using an
antibody which speciﬁcally recognises TOP1ccs (Supplementary
Fig. 1B)35,36. We observed that acute chemical inhibition of p97
caused TOP1cc accumulation (Supplementary Fig. 1C, D). To
strengthen our conclusion that TOP1cc repair requires p97
ATPase activity, we monitored TOP1cc formation by RADAR in
doxycycline-inducible stable cells expressing either wild-type p97
or the dominant-negative EQ variant (+Dox). We observed that
TOP1ccs only accumulated in those cells expressing p97EQ (Fig. 1e,
f). Short-term induction of p97EQ did not cause a substantial
accumulation of ubiquitinated proteins in whole cell extracts,
indicating that impaired TOP1cc clearance in these cells was not a
secondary consequence of the free ubiquitin pool being depleted
(Fig. 1g). These experiments were performed in the absence of
CPT treatment, demonstrating that endogenous TOP1ccs are
common and can be counteracted by p97. Overall, we conclude
that p97 ATPase activity is needed to counteract TOP1cc
accumulation in human cells, as is the case for yeast Cdc4816,17,25.
TEX264 recruits p97 to TOP1ccs. To recognise and process its
diverse substrates, p97 associates with cofactors which directly
bind to p97 via conserved p97 interaction motifs, and typically
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bridge p97 to ubiquitinated substrates through ubiquitin-binding
domains37,38. To identify the p97 cofactor that targets p97 spe-
ciﬁcally to TOP1ccs, we consulted an ongoing mass spectrometry
screen of proteins that interact with p97 inside the nucleus (our
unpublished data). A protein which stood out as a potential
candidate was Testes-expressed 264 (TEX264; Q9Y6I9) because it
possesses a gyrase inhibitory-like (GyrI-like) domain (Fig. 2a). In
E. coli, GyrI-like proteins inhibit the decatenation activity of the
type II topoisomerase, DNA gyrase39,40. On closer analysis of the
TEX264 protein sequence we identiﬁed a putative p97 interaction
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motif, known as a SHP box, located in its unstructured C-ter-
minus, suggesting that TEX264 could be a p97 cofactor (Fig. 2a).
TEX264 also possesses an N-terminal leucine-rich repeat (LRR)
that was shown to tether the protein to the membrane of the
endoplasmic reticulum (ER)41.
To validate a physical association between p97, TEX264, and
TOP1 in vivo, p97 was isolated from doxycycline-inducible stable
HEK293 cells expressing either p97WT- or p97EQ-myc-Strep at near
endogenous levels (Supplementary Fig. 2A). Endogenous TEX264
and TOP1 were present in anti-p97-myc-Strep immunoprecipitates
(Supplementary Fig. 2A). Reciprocal co-immunoprecipitation of
TEX264-FLAG conﬁrmed that endogenous p97 and TOP1 form a
complex with TEX264 in cells (Supplementary Fig. 2C). The
interaction between TEX264 and TOP1 increased markedly in
response to treatment with a clinically relevant dose of CPT,
indicating that TEX264 is recruited to TOP1ccs, along with p97
(Fig. 2b, Supplementary Fig. 2C).
Two recent studies reported a role for TEX264 in the ER41,42.
However, in addition to TOP1 and p97, numerous nuclear
proteins were found to interact with TEX264 by mass spectro-
metry41. We therefore performed biochemical fractionations to
assess the subcellular localisation of TEX264. We found that
TEX264 is present in the cytosol, nucleus, and on chromatin
(Supplementary Fig. 2B). Endogenous TOP1, which was almost
exclusively found in the nuclear/chromatin fractions, readily co-
immunoprecipitated with TEX264-FLAG (Supplementary Fig. 2B,
C). These results show that a subpopulation of TEX264 is nuclear.
Signiﬁcantly less TOP1 co-immunoprecipitated with p97-myc-
Strep in CRISPR-Cas9 TEX264 knockout cells (ΔTEX264) than in
wild-type cells, demonstrating that TEX264 is required to bridge
p97 to TOP1 in vivo (Fig. 2c). We noted that the interaction
between p97 and TOP1 was not notably stimulated by CPT
treatment, possibly due to the highly dynamic way in which p97
processes its substrates. The p97–TOP1 interaction was enhanced
upon treatment with CPT when p97’s ATPase activity was
chemically inhibited, and this interaction was also dependent on
TEX264 (Fig. 2d). We therefore conclude that p97 is recruited to
TOP1ccs by TEX264. All of these interactions are resistant to
benzonase and ethidium bromide, indicating that they are not
indirectly mediated by nucleic acid.
Importantly, TOP1 did not co-immunoprecipitate with either
p97 or TEX264 after treatment with 1 µM CPT for 1 h (Fig. 2c,
Supplementary Fig. 2C, lane 4). This dose causes DNA replication
fork collapse and double strand break (DSB) formation and far
exceeds clinically relevant doses (which are in the nanomolar
range)43–45. This suggests that TEX264 and p97 may only interact
with TOP1 when DNA replication complexes are intact. This is in
line with the published literature as, after DSB formation,
TOP1ccs are resolved by classical DSB repair pathways and their
associated nucleases46–48.
We next attempted to reconstitute the p97–TEX264–TOP1
complex in vitro. We ﬁrst puriﬁed human p97 and wild-type
TEX264 (TEX264WT) from E. coli. TEX264 was puriﬁed without
its hydrophobic N-terminus (i.e. LRR: amino acids 1-33) to
improve its solubility. TEX264WT readily bound p97 in vitro
(Fig. 2e). TEX264WT could also efﬁciently associate with
recombinant TOP1, whereas direct binding between p97 and
TOP1 was weaker (Supplementary Fig. 2D–F). When p97 was
pre-incubated with TEX264 prior to the addition of TOP1, we
observed a signiﬁcant increase in the amount of TOP1 in p97
pulldowns (Supplementary Fig. 2F, G). This demonstrates that
TEX264 can simultaneously bind both p97 and TOP1 and, thus,
physically bridge p97 to TOP1.
TEX264 associates with the N-terminus of p97 (amino acids
1–199), indicating that the interaction is independent of the
nucleotide-bound status of p97, as is the case for many p97
cofactors (Supplementary Fig. 2H)38. Compared with TEX264WT,
a TEX264 variant lacking its putative SHP box (TEX264ΔSHP;
amino acids 273–285), bound much less efﬁciently to p97 in vitro,
suggesting that TEX264 is indeed a p97 cofactor (Fig. 2e).
TEX264 promotes TOP1cc repair and is epistatic with p97 and
TDP1. We next examined the effects of TEX264 inactivation on
TOP1cc repair in unchallenged conditions. Depletion of TEX264
led to signiﬁcant TOP1cc foci accumulation in RPE-1 and U-2
osteosarcoma (U2OS) cells (Figs. 3a, b, 4f). Knockout of TEX264
also caused substantial TOP1cc accumulation in HEK293 cells
(Fig. 3c, d, Supplementary Fig. 3A). This was speciﬁcally due to
loss of TEX264 as expression of exogenous TEX264 in ΔTEX264
cells could completely reverse TOP1cc accumulation (Supple-
mentary Fig. 3B). Exogenous TEX264 could not reverse TOP1cc
accumulation when ΔTEX264 cells were depleted of p97, indi-
cating that TEX264 requires p97 to counteract TOP1cc accu-
mulation (Supplementary Fig. 3B). Moreover, following a short
CPT treatment and release into CPT-free media, TOP1ccs were
rapidly resolved in control cells, but persisted long after CPT
withdrawal in ΔTEX264 cells (Supplementary Fig. 3C, D).
Together, these data demonstrate that TEX264 plays an impor-
tant role in TOP1cc repair.
To test whether the increased levels of TOP1ccs in TEX264-
deﬁcient cells led to an increase in DNA damage, we performed
an alkaline comet assay (Fig. 3e, f). Cells depleted of TEX264
displayed increased levels of basal DNA damage compared with
control cells. Moreover, after CPT treatment, TEX264-depleted
cells exhibited signiﬁcantly delayed DNA damage repair kinetics
—similar to TDP1-depleted cells. When TEX264 and TDP1 were
co-depleted, there was no additive increase in DNA damage upon
CPT treatment nor was there a further delay in DNA repair
kinetics (Fig. 3f). This suggests that TEX264 and TDP1 act within
the same TOP1cc repair pathway. To investigate further whether
TEX264 and TDP1 are epistatic, we monitored TOP1ccs by
RADAR. Depleting TEX264, TDP1, or p97, either alone or in
pairs, resulted in similar increases in basal TOP1cc levels
(Supplementary Fig. 3E–G). Moreover, TEX264- or TDP1-
depleted HeLa cells are sensitive to low doses of CPT, and this
is not enhanced by their co-depletion (Fig. 3g). ΔTEX264
HeLa cells were similarly sensitive to CPT (Supplementary
Fig. 1 The p97 ATPase promotes TOP1cc repair. a RADAR assay to assess TOP1cc accumulation after short interfering (si)RNA-mediated depletion of
p97. Treatment with 1 μM CPT for 1 hour was used as a positive control for TOP1cc induction. Double-stranded (ds)DNA is used as a loading control.
b Immunoblot to conﬁrm p97 depletion. c Quantiﬁcation of A (error bars represent mean ± SEM; n= 2 for CPT (1 μM); n= 3 for siLuc, sip97 #1 and #2;
*P < 0.05; ns, not signiﬁcant; Student’s t-test). d Left: immunoblots of anti-Strep-tag immunoprecipitates prepared from HEK293 transiently expressing
wild-type (WT) or ATPase-defective (E578Q/EQ) p97-myc-Strep. EV denotes empty vector. LE and SE denote long and short exposure, respectively.
Right: quantiﬁcation of three independent experiments (error bars represent mean ± SEM; *P < 0.05; Student’s t-test). e RADAR assay to assess TOP1ccs in
doxycycline (Dox)-inducible HEK293 Flp-In TRex cells expressing the indicated p97 variants. Where indicated, cells were treated with Dox for 36 h.
f Quantiﬁcation of e (error bars represent mean ± SD; n= 2; *P < 0.05; Student’s t-test). g Immunoblots of whole cell extracts prepared from the same cells
as those subjected to RADAR in e. Arrowheads indicate endogenous p97 (lower band) and induced p97-myc-Strep (upper band). Source data are available
online.
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Fig. 3H). Notably, overexpression of TEX264, but not TDP1, in
TEX264-depleted cells reversed their sensitivity to CPT, indicat-
ing that TDP1 alone is not sufﬁcient for TOP1cc repair
(Supplementary Fig. 3I).
We next investigated the function of TEX264’s GyrI-like
domain (Fig. 3h). The crystal structure of the bacterial GyrI
protein, SbmC, revealed that the protein forms a solvent-exposed
surface which, we inferred, may mediate substrate binding49.
Based on this information, we generated TEX264 variants with
single point mutations in conserved residues in or close to its
GyrI-like domain and tested their ability to bind TOP1 (Fig. 3h, i,
Supplementary Fig. 4A, B). Each variant displayed reduced
TO
P1
cc
 fo
ci 
pe
r c
el
l
siL
uc
siT
EX
26
4 #
1
0
20
40
60
80
****
WT
E1
94
A
0.0
0.5
1.0
R
el
at
iv
e 
TO
P1
 b
in
di
ng
 b
y 
TE
X2
64
****
R
el
at
iv
e 
TO
P1
cc
s
siL
uc
ΔT
EX
26
4 #
1
ΔT
EX
26
4 #
2
0
1
2
3 ** *
0 3 6 12 25
10
100
Camptothecin (nM)
Vi
ab
ilit
y 
(%
)
siLuc
siTEX264 #1
siTDP1
siTEX264 #1 +
siTDP1
5
0
5
10
15
20
25
30
35
40
45
45
50
55
60
65
*
*
*
ns
ns
*
**
**
ns
ns
**
ns
ns
****
****
****
ns
ns
***
****
ns
ns
O
liv
e 
ta
il m
om
en
t
siL
uc
siT
EX
26
43
′UT
R
siT
DP
1
siT
EX
26
43
′UT
R +
 s
iTD
P1
siL
uc
siT
EX
26
43
′UT
R
siT
DP
1
siT
EX
26
43
′UT
R +
 s
iTD
P1
siL
uc
siT
EX
26
43
′UT
R
siT
DP
1
siT
EX
26
43
′UT
R +
 s
iTD
P1
siL
uc
siT
EX
26
43
′UT
R
siT
DP
1
siT
EX
26
43
′UT
R +
 s
iTD
P1
siL
uc
siT
EX
26
43
′UT
R
siT
DP
1
siT
EX
26
43
′UT
R +
 s
iTD
P1
Untreated CPT (1 h)
CPT (1 h)
+
Recovery (6 h) CPT (6 h)
**
* **
CPT (1 h)
+
Recovery (3 h)
a b c
d f
h
g
e
si
TE
X2
64
 #
1
TOP1cc DAPI
si
Lu
c
i
2 4 8
TOP1
dsDNA
µg
µg
HEK293 WT
ΔTEX264 #1
ΔTEX264 #2
HEK293 WT
ΔTEX264 #1
ΔTEX264 #2
CPT (1 h)
siLuc
siTDP1 1 33
IP: TEX264-FLAG
TOP1
p97
FLAG (TEX264)
TOP1
p97
FLAG (TEX264)
El
ut
io
n
In
pu
t
LRR
EV WT E1
94
A
Gyrl-like
SHP
194 280 285
TOP1 binding residue
siTEX2643′UTR
siTEX2643′UTR
+
siTDP1
CPT (1 h)
+
recovery (6 h)
0.1 0.2 0.4
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-15000-w
6 NATURE COMMUNICATIONS |         (2020) 11:1274 | https://doi.org/10.1038/s41467-020-15000-w |www.nature.com/naturecommunications
binding to TOP1, but not p97, suggesting that they comprise a
binding surface that enables TEX264 to bind TOP1 (Supplemen-
tary Fig. 4B). We focused on the E194A mutant since mutating
this residue strongly reduced the TEX264–TOP1 interaction and
because this residue resides in a predicted α-helix (amino acids
193–210) that is unique to TEX264 among GyrI-like proteins
(Fig. 3i, Supplementary Fig. 4A & B). When TEX264 expression
was suppressed using siRNA targetting its 3′UTR, U2OS cells
accumulated ~2–3-fold more TOP1cc foci. Wild-type TEX264
could completely reverse this increase, whereas the TOP1-binding
defective variant, E194A, largely failed to do so (Supplementary
Fig. 4C, D). These results demonstrate that the interaction
between TEX264 and TOP1 is important for TOP1cc repair.
Altogether, our data suggest that TEX264 is a crucial TOP1cc
repair factor that is epistatic with TDP1.
TEX264 can bind SUMOylated TOP1. Most p97 cofactors have
ubiquitin-binding domains that direct p97 to ubiquitinated
proteins37. TEX264, however, does not appear to contain
ubiquitin-binding motifs. As the ubiquitin-like protein, SUMO1,
is proposed to facilitate TOP1cc repair, and Cdc48 has been
shown to act on SUMOylated substrates, such as Rad52, we
investigated whether TEX264 is linked to SUMO1-mediated
TOP1cc repair25,50–52.
CPT treatment induced a dose-dependent increase in SUMO1-
modiﬁed TOP1, indicating that TOP1ccs are SUMOylated
(Supplementary Fig. 5A). We reasoned that SUMO1 might serve
as an additional signal for the recruitment of TEX264. In the
absence of TEX264 and p97, SUMO1-modiﬁed TOP1 would
therefore be expected to accumulate. Indeed, depletion of either
TEX264 or p97 caused SUMO1-modiﬁed TOP1 to accumulate
(Supplementary Fig. 5B, C). We next sought to establish whether
SUMOylation plays a role in TOP1cc repair. Consistent with
previous reports, TOP1cc levels were initially lower when the E2
SUMO ligase, UBC9, was depleted (Fig. 4a, b)53. However, after
CPT treatment, TOP1cc levels were strikingly higher in UBC9-
depleted cells than in control cells and this was similar in extent
to p97- or TEX264-inactivated cells (Fig. 4a, b). These data
demonstrate that SUMOylation promotes the resolution of
TOP1ccs, as previously reported, and suggest its importance for
mediating TEX264 function in TOP1cc repair3,51,52,54,55.
Bioinformatic analysis subsequently revealed the presence of two
putative SUMO-interacting motifs (SIMs) located in the GyrI-like
domain of TEX264 (Fig. 4c). We therefore tested whether TEX264
directly interacts with SUMO. We found that TEX264 bound to free
SUMO1, but not SUMO2 (neither free SUMO2 nor poly-SUMO2
chains; Fig. 4d, Supplementary Fig. 5D). Mutation of either of the
putative SIMs strongly diminished SUMO1 binding, suggesting that
both SIMs contribute to SUMO1 binding to some extent (Fig. 4d).
Modiﬁed species of TOP1 co-immunoprecipitated less readily with
the SIM2-mutated variant of TEX264 (TEX264SIM2*) than they did
with either wild-type TEX264 (TEX264WT) or the SIM1-mutated
variant (TEX264SIM1*; Supplementary Fig. 5E). To gain insight into
why SIM2 appears to be more important for binding to modiﬁed
species of TOP1, we generated a homology-based structural model
of the GyrI-like domain of TEX264 (Fig. 4c). This revealed that
SIM2 comes into closer proximity than SIM1 to the TOP1-binding
surface (indicated in magenta in Fig. 4c) on TEX264.
To address speciﬁcally whether TEX264 interacts with
SUMO1-modﬁed TOP1 in a SIM2-dependent manner, we
performed tandem afﬁnity puriﬁcations (TAP) from HEK293
cells co-expressing FLAG-tagged TEX264 and HA-tagged
SUMO1 (Fig. 4e). We ﬁrst puriﬁed TEX264–FLAG protein
complexes under native conditions (1st IP). From here, we
isolated HA-tagged SUMO1-modiﬁed interacting partners of
TEX264 under denaturing conditions (2nd IP; Fig. 4e). This
analysis revealed that many SUMOylated proteins exist in
complex with TEX264WT and, to a slightly lesser extent, with
TEX264SIM2* (Fig. 4e). When HA-SUMO1 eluates were probed
speciﬁcally for TOP1, we observed that ~70% less SUMO1-
modiﬁed TOP1 co-immunoprecipitated with TEX264SIM2* than
with TEX264WT (Fig. 4e). These data demonstrate that TEX264
binds SUMO1-modiﬁed TOP1 and that this binding is strongly
reduced when SIM2 is mutated.
In turn, TEX264WT and TEX264SIM1* could reverse TOP1cc
accumulation in TEX264-depleted U2OS cells, whereas
TEX264SIM2* displayed a strongly reduced ability to do so
(Fig. 4f, g). Overall, our results demonstrate that TEX264 can
bind both SUMO1-modiﬁed and unmodiﬁed TOP1 (Figs. 2b, 4e,
Supplementary Fig. 2D). We hypothesise that the TEX264–
SUMO1 interaction may facilitate or stabilise the binding between
TEX264 and TOP1ccs. In this way, TOP1 SUMOylation upon
TOP1cc formation may enable TEX264 to be recruited more
efﬁciently to TOP1ccs.
TEX264 promotes SPRTN-dependent TOP1cc repair. In prin-
ciple, TEX264 and p97 might together be capable of recognising
and remodelling TOP1ccs to facilitate access of TDP1 to the
phosphodiester bond that links TOP1 to DNA. Whether other
factors contribute remained unclear. As p97 forms a homohexamer,
it can bind multiple cofactors at a time38,56. It was recently
demonstrated that another p97 cofactor, SPRTN, is a metallopro-
tease which can proteolytically cleave TOP1, amongst other
DNA–protein crosslinks (DPCs), during DNA replication18,19,57–60.
To assess the interplay of TEX264 and SPRTN in vivo, we
depleted both proteins in HeLa cells, either alone or in
combination, and assessed cellular sensitivity to CPT. Depletion
of SPRTN alone sensitised cells to CPT, albeit to a lesser extent
Fig. 3 TEX264 counteracts TOP1ccs. a Immunoﬂuorescent detection of TOP1ccs (green) in RPE-1 cells transfected with the indicated siRNAs. DAPI 4′,6-
diamidino-2-phenylindole. Scale bar, 10 µm. b Quantiﬁcation of a. Red line indicates median. Data are representative of two independent experiments.
Signiﬁcance determined by Mann–Whitney test. c Slot blot analysis of TOP1ccs prepared from WT or ΔTEX264 HEK293 cells using the RADAR assay.
d Quantiﬁcation of c (error bars represent mean ± SD; n= 2; **P < 0.01, *P < 0.05; Student’s t-test). e Representative images of cells analysed by alkaline
comet assay in f. f Alkaline comet assay performed in RPE-1 cells treated with the indicated combinations of siRNAs. Cells were treated with CPT (100 nM)
for 1 or 6 h(s) and allowed to recover as indicated. Quantiﬁcation of >100 cells per condition from one representative experiment is shown, and the
experiment was repeated two times. Whisker box plots show median values and data within the 10–90 percentile. Statistical analysis was performed using
Kruskal–Wallis ANOVA with multiple comparisons, with Benjamini–Hochberg post-test. g Colony forming assay to assess the viability of HeLa cells
transfected with the indicated siRNAs. Cells were treated for 24 h with the indicated doses of CPT, released into normal media for 7 days, then ﬁxed and
stained. Viability represents the number of colonies in each sample expressed as a percentage of the number of colonies formed in the corresponding
untreated sample (error bars represent mean ± SD; n= 2). h Schematic diagram of the TEX264 protein indicating the location of residue E194. i Left:
Immunoblots of FLAG immunoprecipitates prepared from ΔTEX264 HEK293 cells transiently expressing the indicated versions of FLAG-tagged TEX264.
Right: Corresponding quantiﬁcations of four independent experiments (mean ± SEM; ****P < 0.0001; ***P < 0.0005; Student’s t-test). Source data are
available online.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-15000-w ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:1274 | https://doi.org/10.1038/s41467-020-15000-w |www.nature.com/naturecommunications 7
than TEX264 depletion (Supplementary Fig. 6A, B). However, co-
depletion of SPRTN did not further sensitise TEX264-depleted
cells to CPT, indicating that these proteins can co-operate to
repair TOP1ccs but also that TEX264 has SPRTN-independent
roles in counteracting TOP1ccs. To explore how TEX264
regulates SPRTN-dependent TOP1cc processing we immunopre-
cipitated SPRTN-SSH from wild-type and TEX264-depleted
HEK293 cell extracts. Endogenous TOP1, p97, and TEX264 co-
immunoprecipitated with SPRTN-SSH in wild-type cell extract
(Fig. 5a). Depletion of TEX264 strongly reduced the interaction
between SPRTN and TOP1 without affecting total TOP1 levels or
the interaction between SPRTN and p97 (Fig. 5a). This indicates
that TEX264 recruits p97–SPRTN sub-complexes to TOP1.
A recent structural study demonstrated that the protease active
site of SPRTN is located within a narrow groove that is only
accessible to ﬂexible peptide structures and not globular proteins
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such as TOP161. Therefore, large DPCs, such as TOP1ccs, likely
need to undergo remodelling before their cleavage. Consistent
with this, we previously demonstrated that SPRTN preferentially
cleaves unstructured protein regions, most likely because they can
more readily access SPRTN’s active site19. We therefore
hypothesised that p97 might be needed to remodel TOP1ccs in
order to make them more amenable to cleavage by SPRTN. To
test this model, we performed an in vitro assay to assess the
ability of puriﬁed SPRTN to process TOP1ccs isolated from cells
by CsCl-gradient fractionation. SPRTN alone could process a
small proportion of TOP1ccs. However, this activity was
enhanced when TOP1ccs were pre-incubated with p97 or
TEX264 and p97 prior to the addition of SPRTN (Supplementary
Fig. 6C, D).
An implication of this model is that SPRTN would require its
association with p97 to promote TOP1cc repair. To test this, we
generated doxycycline-inducible stable cell lines expressing either
wild-type SPRTN or a SPRTN point mutant that cannot bind p97
(SHP*; G255A, G257A, L260A, G261A; Fig. 5b). Wild-type
SPRTN completely reversed TOP1cc accumulation in cells in
which endogenous SPRTN was depleted with an siRNA sequence
targetting its 3′UTR (Fig. 5c). However, the p97 binding-defective
variant failed to do so, demonstrating that the SPRTN–p97
interaction is required for TOP1cc repair (Fig. 5c). Interestingly,
we found that depletion of TEX264, unlike SPRTN, did not cause
total DPCs to accumulate, suggesting that TEX264 may
speciﬁcally promote SPRTN-dependent TOP1cc repair (Fig. 5e, f).
TEX264 acts at replication forks. SPRTN’s function is tightly
coupled to DNA replication19,24,60,62–64. Based on this and the
fact that TOP1ccs can stall DNA replication, we asked whether
TEX264 acts near replication forks to prevent TOP1ccs from
impeding fork progression. To identify interacting partners of
TEX264, we isolated chromatin from doxycycline-inducible stable
HEK293 cells expressing TEX264-SSH and analysed anti-Strep-
tag immunoprecipitates by LC–MS/MS (Source Data). In addi-
tion to TOP1 and p97, we detected numerous replication factors,
including PCNA and components of the MCM complex. We
validated these interactions in co-immunoprecipitation experi-
ments (Fig. 6a). Depletion of TEX264 with either of two different
siRNA sequences in four different cell lines led to a signiﬁcant
reduction in EdU incorporation, which is suggestive of a defect in
DNA replication (Fig. 6b). Furthermore, measurement of DNA
replication fork velocity by DNA ﬁbre assay revealed that
depletion of TEX264 or p97 caused DNA replication forks to
progress more slowly (Supplementary Fig. 7A).
We next investigated whether TEX264 localises to sites of DNA
replication. Using confocal microscopy, we observed that TEX264
localises to the nuclear periphery, where it partially co-localises
with newly synthesised DNA (i.e. EdU-positive DNA), SPRTN,
and TOP1ccs (Fig. 6c, d; Supplementary Fig. 7B–D). A recent
study demonstrated that the N-terminal LRR of TEX264 is a
transmembrane segment that tethers it to the membrane of the
ER41. When we deleted this segment (TEX264ΔLRR; amino acids
1–33), TEX264 redistributed into the cytoplasm as well as the
nucleoplasm (Fig. 6c, d, Supplementary Fig. 7B). This suggests
that a subset of TEX264 may be localised to the inner nuclear
membrane via its LRR. Within the nucleus, TEX264ΔLRR also
partially co-localised with nascent DNA, SPRTN foci, and
TOP1ccs (Fig. 6c, d, Supplementary Fig. 7D). Like some other
GyrI-like proteins, recombinant TEX264 (puriﬁed without its
LRR) binds DNA when analysed by electrophoretic mobility shift
assay (EMSA; Supplementary Fig. 7E)65. These data indicate that
the TEX264 protein has properties that enable it to associate with
DNA, replication forks, TOP1ccs, and SPRTN, independently of
its LRR/membrane localisation. Collectively, our data support a
model in which TEX264 is present at the nuclear periphery where
it can associate with SPRTN and DNA replication forks.
To biochemically demonstrate that TEX264 associates with
DNA replication forks, we isolated newly replicated DNA from
cells by isolation of proteins on nascent DNA (iPOND)66.
Consistent with our microscopy data, TEX264 was detected,
along with p97 and SPRTN, at/near replication forks by iPOND
(Supplementary Fig. 7F). When cells were treated with CPT (100
nM, 1 h), we detected a striking increase in the amount of TOP1
at replication forks in ΔTEX264 cells compared with control cells
(Supplementary Fig. 7F). This strongly supports the notion that
TEX264 counteracts TOP1cc accumulation near replication forks
(Fig. 6h). The amount of SPRTN detected at replication forks was
slightly reduced in ΔTEX264 cells, suggesting TOP1ccs are
common substrates of SPRTN during DNA replication (Supple-
mentary Fig. 7F). In ΔTEX264 cells, p97 was still detected at DNA
replication forks. This is likely because p97 has pleiotropic roles
in DNA replication and can be recruited to replication forks by
different p97 cofactors to, for example, regulate DNA replication
origin ﬁring or promote DNA replication termination by
unloading the CMG helicase (Supplementary Fig. 7F)67–71.
Since replication-blocking TOP1ccs can induce DNA damage,
we reasoned that reducing the prevalence of TOP1ccs should
alleviate the DNA damage observed in TEX264-deﬁcient cells.
Strikingly, depletion of TOP1 strongly reduced DNA strand break
accumulation in TEX264-depleted cells, as measured by γH2AX
(Fig. 6e–g). Thus, the DNA strand breaks observed in TEX264-
deﬁcient cells can largely be attributed to the deleterious action of
the TOP1 protein and the consequent formation of endogenous
TOP1ccs.
Discussion
TOP1ccs are highly cytotoxic endogenous DNA lesions that can
also be exploited in cancer therapy. It is anticipated that targetting
TOP1cc repair factors could enhance the clinical efﬁcacy of TOP1
poisons and/or overcome drug resistance1. We have elucidated a
key aspect of the TOP1cc repair process, speciﬁcally how TOP1ccs
are processed upstream of the phosphodiesterase TDP1. The bulky
nature of the TOP1 protein restricts TDP1’s access to the phos-
phodiester bond that links TOP1 to DNA. Heat denaturation or
Fig. 4 TEX264 can bind SUMO1-modiﬁed TOP1. a Analysis of TOP1ccs isolated by RADAR from the indicated cell lines. Where indicated, cells were
treated with 1 μM CPT for 30min. b Quantiﬁcation of a (error bars represent mean ± SD; n= 2). c Above: schematic diagram of TEX264, indicating the
location of its putative SUMO-interacting motifs (SIMs). Below: structural model of the GyrI-like domain of TEX264 generated using Phyre2. Residues
158–184 are highlighted in pink. Putative SIMs are highlighted in yellow. d Immunoblot of GFP & SUMO1 after incubation of puriﬁed GFP-tagged WT & SIM
mutant TEX264 with free SUMO1. e Above: tandem-afﬁnity puriﬁcations (TAP) procedure to identify SUMO1–modiﬁed proteins that interact with TEX264.
Below: immunoblots of TAP experiment performed in ΔTEX264 HEK293 expressing the indicated variants of TEX264 and HA-SUMO1. SE and LE denote
short and long exposure, respectively. Asterisks indicate SUMO1-modiﬁed versions of TOP1. f Immunoﬂuorescent detection of TOP1ccs (green) and
TEX264-FLAG (red) in U2OS cells transfected with the indicated siRNAs and cDNAs. Scale bar, 10 μm. g Quantiﬁcation of experiments represented
in f. Red line indicates median. Data are representative of two independent experiments. Statistical analysis was performed using Kruskal–Wallis ANOVA
with multiple comparisons, with Dunn's post-test. Source data are available online.
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pre-digestion of TOP1ccs with trypsin enables TDP1 activity
in vitro, however, a detailed understanding of TOP1cc processing
upstream of TDP1 in vivo has been lacking11–13.
Here we report that TEX264 acts with the p97 ATPase and
SPRTN metalloprotease to repair TOP1ccs. We found that
TEX264 is recruited to TOP1ccs and binds the TOP1 protein via
residues clustered in and around its GyrI-like domain. TEX264
also possesses SIMs that enable it to interact with SUMO1-
modiﬁed TOP1. TEX264 interacts with p97 and SPRTN and
bridges their interactions with TOP1. Our data demonstrate that
the ATPase activity of p97 is required for TOP1cc repair and
suggest that p97 facilitates the proteolytic digestion of TOP1ccs
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by SPRTN. The removal of the bulk of the protein component of
a TOP1cc could then enable TDP1 to excise the remnant DNA-
bound peptide12.
Two recent studies reported that TEX264 is embedded in the
ER membrane via its transmembrane N-terminal LRR, where it
functions as an ER-phagy receptor41,42. Our ﬁnding that deleting
the LRR of TEX264 causes it to mobilise into the nucleoplasm
suggests that a subset of TEX264 is localised at the inner nuclear
membrane. TOP1 has recently been shown to predominantly act
on heterochromatin that is tethered to the nuclear envelope,
presumably because these genomic regions are most prone to
topological disruptions72. It is therefore plausible that TOP1ccs
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may be most prevalent in the vicinity of the nuclear envelope.
This is a particularly appealing model considering that TEX264
and SPRTN co-localise with nascent DNA at the nuclear envel-
ope, where heterochromatin is tethered. Alternatively, TOP1ccs
may be relocalised to the nuclear envelope, as has been demon-
strated for other SUMOylated proteins and some types of DNA
lesions73–75. It is perhaps less likely that TEX264 only operates on
a speciﬁc subset of TOP1ccs, since numerous experimental
approaches demonstrated that TEX264 and TDP1 act in the same
pathway to repair endogenous TOP1ccs. Our data therefore
suggest that TOP1cc repair may occur at the nuclear periphery.
There may otherwise be a mechanism of releasing TEX264 from
the nuclear envelope or alternative TEX264 isoforms which lack
the LRR.
TEX264 can also bind the autophagosomal protein LC3B41,42.
In line with our ﬁndings, proteomic analyses conducted by An
et al. (2019) also identiﬁed TOP1 and VCP/p97 as highly abun-
dant TEX264-interacting partners, amongst numerous other
nuclear proteins. Whether TEX264’s role in autophagy is linked
to the observations presented here is an interesting line of future
enquiry. The SUMO system, Cdc48/p97, and autophagy have
previously been linked to DPC repair in yeast17. The Cdc48
cofactor, Wss1, relocalises to vacuoles in response to genotoxic
stress and this is proposed to promote the clearance of TOP1ccs
via autophagy17.
In addition to Wss1, the Cdc48 cofactor, Ufd1, possesses a SIM
which is important for TOP1cc repair in yeast25. While the same
SIM in yeast Ufd1 is not conserved in humans, we do not rule out
a role for Ufd1 in TOP1cc repair in human cells. For instance,
p97 hexamers can bind cofactors in a hierarchical manner, as
described for Ufd-Npl4 and FAF1, which can provide an addi-
tonal layer of substrate-speciﬁcity control56.
The function of Wss1 in TOP1cc repair depends on Cdc48 but
the reasons for this were unclear16,17. It was speculated that
Cdc48 could be involved in the removal of peptide remnants
generated by proteolysis or in remodelling the TOP1 protein to
facilitate its proteolytic digestion16. Our data suggest that the
p97–TEX264 complex enables TOP1cc proteolysis by SPRTN.
This conclusion is supported by a recent strutural analysis of
SPRTN’s active site61. The catalytic core of SPRTN is located
within a narrow groove that is only accessible to small, ﬂexible
peptides, such as the disordered tails of histones. By contrast,
TOP1ccs have a large, globular structure and lack ﬂexible linker
regions that could be accommodated by the substrate-binding
groove of SPRTN. Therefore, the requirement of TEX264 and p97
in TOP1cc repair likely reﬂects the need to recognise and remodel
the TOP1 protein to render it more amenable to cleavage by
SPRTN. The fact that TEX264 appears to be dispensable for the
clearance of the majority of DPCs supports the existence of a
specialised TOP1cc repair complex consisting of TEX264, p97,
and SPRTN.
It will be interesting to explore whether this mode of SPRTN
recruitment is more widely applicable to other SPRTN substrates,
since little is known about how SPRTN is recruited to, and
recognises, speciﬁc DPCs. SPRTN can be recruited to stalled
replication forks by binding to PCNA (via its PIP box) or ubi-
quitinated proteins (via its UBZ)24,62,76–78. However, some recent
evidence indicates that these domains are not essential for the
recruitment of SPRTN to chromatin in response to DPC for-
mation nor for DPC repair18,20,59,79.
Finally, our ﬁndings raise the possibility that the p97 system
could be targetted to counteract clinical resistance to CPT.
Methods
Cell culture. Human HEK293, U2OS, RPE-1, and HeLa cells were obtained from
ATCC. All cell lines were cultured in DMEM containing 10% FBS and 5% Peni-
cillin/Streptomycin. All cell lines were regularly screened for mycoplasma using a
MycoAlert™ Mycoplasma Detection Kit.
Generation of cell lines. To generate CRISPR–Cas9 TEX264 knockout cells, two
plasmids—a CRISPR/Cas9 KO plasmid containing guide RNA targetting TEX264
(sc-417333), and a homology-directed repair plasmid containing a puromycin
resistance cassette (sc-417333-HDR)—were purchased from Santa Cruz. 2.5 μg of
each plasmid was transfected into early-passage HEK293 and HeLa cells using
Fugene HD (Promega). After 72 h, media supplemented with puromycin was
added to the cells. The puromycin dose required to kill wild-type cells was
determined to be: 1.25 μg/mL for HEK293 cells and 0.6 μg/mL for HeLa cells. After
72 h, the puromycin-containing media was removed and cells were sorted using a
cell sorter into single-cell populations on a 96-well plate. TEX264 expression was
analysed by immunoblotting. Multiple clones of each cell line showing loss of all
detectable TEX264 were selected for subsequent analysis.
Flp-In™ T-REx™-293 cells (ThermoFisher Scientiﬁc) were cultured in DMEM
complete media containing Zeocin (100 µg/mL; ThermoFisher Scientiﬁc) and
Blasticidin (15 µg/mL; Cambridge Biosciences). TEX264 or SPRTN-SHP* cDNA
was cloned into the pCDNA5/FRT/TO-cSSH vector. Cells were grown in complete
media supplemented with Blasticidin (15 µg/mL) and co-transfected with pCDNA5‐
FRT/TO-TEX264-SSH or pCDNA5‐FRT/TO-SPRTN-SHP*-SSH and the Flp
recombinase expression plasmid, pOG44 (ThermoFisher Scientiﬁc). After 2 days,
single colonies were selected and expanded in DMEM complete media containing
Blasticidin (15 µg/mL) and Hygromycin B (50 µg/mL; Caymen Chemical). Clones
were then tested for TEX264-SSH or SPRTN-SHP*-SSH expression upon induction
with 1–1.2 µg/mL Doxycycline by immunoblotting. Flp-In T-Rex-293 cells
expressing miRNAs targetting TDP1 were generated as previously described80.
Cellular fractionations. The cytoplasmic fraction was obtained by resuspending
cells in buffer A (10 mM HEPES, 10 mM KCl, 340 mM sucrose, 10% glycerol,
protease and phosphatase Inhibitors, and 2 mM EDTA). Triton X-100 was added
to a ﬁnal concentration of 0.1% and cells were incubated on ice for 5 min. Cells
were then centrifuged at 350×g for 3 min. The remaining pellet (nuclei) was washed
in buffer A without Triton X-100. Nuclei were ruptured by resuspending in buffer
B (3 mM EDTA, 0.2 mM EGTA, 5 mM HEPES pH 7.9, protease and phosphatase
inhibitors). The nuclear fraction was then centrifuged at 1700×g for 5 min and the
supernatant was collected as the nuclear soluble fraction. The chromatin pellet was
washed twice in Benzonase buffer (50 mM Tris–HCl pH 7.9, 50 mM NaCl, 5 mM
KCl, 3 mM MgCl2, and protease and phosphatase inhibitors) and digested in
Benzonase buffer, supplemented with 125 U of Benzonase (Merk Millipore) either
at room temperature for 30 min or overnight rolling at 15 rpm at 4 °C. Samples
were then centrifuged at 20,000×g for 5 min, the supernatant was collected as the
chromatin soluble fraction.
Fig. 6 TEX264 acts at replication forks. a Immunoblots of anti-Strep-tag immunoprecipitates prepared from doxycycline (Dox)-inducible TEX264-SSH
HEK293 Flp-In TRex cells, incubated with and without Dox. b Measurement of EdU incorporation rates in four different cell lines treated with the indicated
siRNAs. EdU incorporation is plotted as a percentage of the corresponding control cells. Cells were incubated with 10 µM EdU for 30min prior to collection
(error bars represent mean ± SEM; ****P < 0.0001; ***P < 0.0005; **P < 0.01, *P < 0.05; Student’s t-test; experiments were performed at least three times).
c Confocal images of U2OS cells transfected with the indicated cDNAs encoding SSH-tagged variants of TEX264 and stained with an anti-HA antibody.
TEX264ΔLRR image was deconvolved. Cells were treated with 10 µM EdU for 30min before ﬁxation. EdU was labelled using a Click-iT™ Alexa Fluor imaging
kit. White arrowheads indicate examples of co-localisation. Scale bars, 5 μm (large panels) and 2 μm (magniﬁed panels). See also Supplementary Fig. 7C.
d Same as in c, except cells were co-transfected with FLAG-tagged SPRTN and co-stained with an anti-FLAG antibody. e Representative images of HeLa
cells transfected with the indicated siRNA and stained with an antibody against γH2AX (phosphorylated on Ser139). f Quantiﬁcation of the mean nuclear
γH2AX intensity for experiment in e (****P < 0.0001; one-way ANOVA; red line indicates mean values). At least 100 nuclei were measured per condition.
Scale bar, 20 μm. g, Immunoblots to conﬁrm the efﬁcacy of TEX264 and TOP1 depletions. h Proposed model: TEX264 is tethered at the nuclear periphery
by its LRR. TEX264 binds to unmodiﬁed and SUMO1-modiﬁed TOP1 and counteracts TOP1cc accumulation by recruiting p97-SPRTN sub-complexes to
TOP1ccs. S1 denotes SUMO1. Source data are available online.
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Immunoprecipitation. Cells were lysed in IP lysis buffer (50 mM Tris, pH 7.4,
150 mM NaCl, 1 mM EDTA, 0.5% Triton X-100, supplemented with protease and
phosphatase inhibitors) and incubated on a rotator at 4 °C for 10 min. Chromatin
was then pelleted by centrifugation for 5 min at 1000×g and then digested with
100 U/mL Benzonase at room temperature in Benzonase buffer (2 mM MgCl2,
50 mM Tris, pH 7.4, 150 mM NaCl). For denaturing IPs, samples were supple-
mented with SDS (ﬁnal concentration 1%) and incubated on ice for 10 min.
Denaturing IPs were quenched with Triton X-100 (to a ﬁnal concentration of 1%).
Lysates were supplemented with ethidium bromide (50 μg/mL) and incubated with
anti-FLAG M2 agarose (Sigma-Aldrich), Strep-Tactin Sepharose (IBA), or GFP-
Trap agarose (Chromotek) for 1–3 h(s) on a rotator at 4 °C, washed three times
with IP wash buffer (150 mM NaCl, 50 mM Tris–HCl; 0.5 mM EDTA), and
resuspended in 2 × Laemmli buffer. For TAP experiments, cells were grown on
245 × 245 mm cell culture dishes (two per condition). Immunoprecipitation of
TEX264-FLAG was performed as described above. After TEX264-FLAG was
captured, samples were boiled for 5 min in 1% SDS then quenched with 1% triton
and incubated with anti-HA beads (Thermo Fisher) for 16 h at 4 °C with rotation.
The next day samples were washed three times in IP wash buffer and eluted in 2×
Laemmlli buffer.
Mass spectrometry sample preparation and analysis. YFP-TOP1: HEK293 cells
were transfected with cDNA encoding YFP-tagged TOP1. After 48 h, chromatin
was isolated from these cells as described above. Samples were incubated with GFP-
Trap agarose for 3 h. Proteins were eluted using Laemmli buffer. Samples were
reduced (5 mM DTT ﬁnal concentration) and alkylated (20 mM iodacetimide ﬁnal
concentration) for 30 min at room temperature (each step) prior to performing a
double methanol and chloroform protein precipitation to remove SDS. Protein
pellets were solubilised with 8M Urea in 20 mM HEPES (pH 8) and digested with
immobilised trypsin for 16 h at 37 °C (Pierce; Urea ﬁnal concentration < 1M)
following the standard in-solution digest protocols. The resulting tryptic peptides
were then puriﬁed by solid phase extraction using SOLA HRP SEP cartridges
(ThermoFisher) and dried81.
Ten percent of the tryptic peptides were analysed using a nano LC–MS/MS
workﬂow based on a Dionex Ultimate 3000 UPLC connected to an Orbitrap Fusion
Lumos (both Thermo Instruments). Peptides were separated on an EASY-Spray
column (500 mm × 75 μm) over one hour gradient of 2–35% acetonitrile in 5%
dimethyl sulfoxide/0.1% formic acid (ﬂow rate of 250 nl/min) and analysed on the
Orbitrap Fusion Lumos using the universal method (MS1 in the Orbitrap at 120k
resolution, AGC target of 4e5; MS/MS: ion trap rapid scan mode, CID
fragmentation at 35% collision energy, AGC target of 4.0E3 for up to 250 ms).
TEX264-SSH: Flp-In TRex HEK293 cells inducibly expressing SSH-tagged
TEX264 were either left untreated or incubated overnight with 1.2 µg/mL
Doxycycline. Cells were lysed in a buffer composed of 20 mM HEPES pH 7.45,
10 mM KCl, 137 mM NaCl, 0.25% digitonin, 20 mM NEM, 5 mM EDTA, and
protease and phosphatase inhibitors. The chromatin pellet was washed once in lysis
buffer supplemented with 0.1% Triton X-100, and three times in Benzonase buffer
(25 mM NaCl, 25 mM Tris–HCl pH 7.9, 5 mM KCl, 2 mM MgCl2, supplemented
with protease and phosphatase inhibitors). Chromatin was digested in buffer
supplemented with 125 U Benzonase overnight at 4 °C on a rotating wheel.
Samples were incubated with Strep-Tactin Sepharose for 2 h with rotation at 4 °C,
after which the beads were washed three times in a buffer composed of 50 mM
NaCl, 5 mM KCl, 50 mM Tris–HCl pH 7.5, 0.025% NP-40. Proteins were eluted by
adding 2.5 mM biotin in 1x IP buffer and shaking the samples for 15 min at 4 °C.
The samples were processed for MS by in solution digestion. In brief, the samples
were reduced by addition of DTT to a ﬁnal concentration of 5 mM and incubated
for 30 min at room temperature. Iodoacetic acid (IAA) was then added to prevent
to reformation of disulphide bridges to a ﬁnal concentration of 20 mM and
incubated for 30 min at room temperature. The proteins were then precipitated by
the addition of methanol and chloroform. The pellet was then resuspended in 6 M
Urea and sonicated for 2 min using the Bioruptor (5 s on, 5 s off for 10 cycles) to
solubilise the protein. The samples were then diluted with ddH2O to dilute the
Urea to below 1M. Trypsin was then added to a concentration of 200 ng/µL and
incubated at 37 °C overnight. The following morning, formic acid was added to a
ﬁnal concentration of 0.1% to decrease the pH and prevent further trypsin
digestion. The protein peptides were then puriﬁed using a SEP-PAK column and
run on an OrbiTrap LTQ Velos Elite Mass Spectrometer (30k resolution, top 20,
collision induced dissociation)82.
Data analysis. Peptides and proteins were identiﬁed by searching the MS raw ﬁles
against the Human SwissProt database downloaded in June 2017 (containing
20,206 sequences) for YFP-TOP1 and in February 2015 (20,274 sequences) for
TEX264-SSH. MASCOT data outputs were ﬁltered by applying a 20 ion cut off and
1% FDR above identity or homology threshold. The mass spectrometry proteomics
data have been deposited to the ProteomeXchange Consortium via the PRIDE
partner repository with the dataset identiﬁer PXD017239 and 10.6019/
PXD01723983.
Protein puriﬁcation and in vitro interaction assays. SPRTN was puriﬁed as
previously described19. p97 was cloned into a pET21a vector (original vector
pCDNA3.1 p97-S-tag was a gift from J. Christianson) and puriﬁed with a
C-terminal S-Tag from Rosetta E. coli with S-protein Agarose (Merck Milipore)
using standard methods. TEX264 was puriﬁed without its hydrophobic N-terminus
(amino acids 1-25; ΔNT) to render the protein more soluble and enable pur-
iﬁcation. ΔNT TEX264 was cloned into a pET21a vector (with a C-terminal His-
tag) and expressed in Rosetta E. coli. Cells were grown at 37 °C and induced for 6 h
with 1 mM IPTG upon reaching an OD600 of 0.6. For ΔNT TEX264 the tem-
perature was dropped to 21 °C, whereas for ΔNT TEX264ΔSHP and p97 the tem-
perature was kept at 37 °C. Cultures were centrifuged at 5000×g for 30 min and the
pellets frozen at −80 °C overnight. The thawed pellets were resuspended in
resuspension buffer (800 mM NaCl, 20 mM Tris–HCl pH 7.0) containing 1%
Triton X-100 and 1 mM PMSF. Lysozyme was added and incubated on ice for
30 min followed by sonication (two minutes 20% power, 50% pulsing, Ultrasonic
Homogeniser Model 300V/T, Biologics Inc.) and centrifugation at 20,000×g for
30 min. Ni-NTA agarose (Qiagen) pre-washed with resuspension buffer was
incubated with the lysate at 4 °C for 2 h with rolling at 15 rpm. This was cen-
trifuged at 500×g for 5 min and the supernatant removed. Beads were washed twice
with resuspension buffer for 15 min rolling at 15 rpm at 4 °C (once with resus-
pension buffer supplemented with 50 mM Imidazole and then with 100 mM
Imidazole). Proteins were eluted from the beads using resuspension buffer with a
gradient of 200–1M Imidazole. The fractions were analysed by SDS–PAGE and
Coomassie (Instant blue, Expedeon) and pooled accordingly. The buffer was
exchanged three times for storage buffer (150 mM NaCl, 10 mM Tris–HCl pH 7.5,
0.1 mM EDTA, 15% Glycerol) using EMD Millipore Amicon™ Ultra-15 Centrifugal
Filter Units (Fisher Scientiﬁc) and subsequently stored at −80 °C.
Protein interaction studies were performed as follows: p97 was coupled to S-
protein Agarose for 2 h at 4 °C in buffer containing 137 mM NaCl, 20 mM
Tris–HCl pH 7.0, then incubated for 2 h with TEX264WT, TEX264ΔSHP, and/or
recombinant TOP1 (Inspiralis) in the same buffer, supplemented with 0.5% Triton
X-100. TEX264WT was coupled to HisPur™ Ni-NTA Magnetic Beads (Thermo
Fisher), prior to incubation for 2 h with recombinant TOP1 in a buffer composed
of 137 mM NaCl and 20 mM Tris–HCl pH 7.0. Reactions were terminated by the
addition of Laemmli buffer and resolved by SDS–PAGE.
DNA-binding assay. DNA 5′ IRDye800-labelled probes (Integrated DNA Tech-
nologies) were either used as single stranded (ATTCGATCGGGGCGGGGC-
GAGC) or double stranded (annealed to a complementary unlabelled strand
(GCTCGCCCCGCCCCGATCGAAT; Eurogentec) templates. The probes were
incubated with BSA, Sp1 (gift from G. Dianov), or TEX264WT, as indicated, in
protein storage buffer (150 mM NaCl, 10 mM Tris–HCl pH 7.5, 0.1 mM EDTA,
15% Glycerol) for 15 min at 37 °C. Samples were resolved on a 0.5% agarose gel in
TBE at 4 °C before visualisation using the Odyssey image analysis system (Li-Cor
Biosciences).
Rapid approach to DNA adduct recovery. DPCs were isolated using a modiﬁed
RADAR assay34. Cells were grown to ~70% conﬂuency then lysed in M buffer
(MB), containing 6M guanidine thiocyanate, 10 mM Tris–HCl (pH 6.8), 20 mM
EDTA, 4% Triton X-100, 1% N-lauroylsarcosine and 1% dithiothreitol. DNA was
precipitated by adding 100% ethanol, then washed three times in wash buffer
(20 mM Tris–HCl pH 7.4, 50 mM NaCl, 1 mM EDTA, and 50% ethanol), and
solubilised in 8 mM NaOH. DNA concentrations were quantiﬁed by NanoDropTM
and conﬁrmed by slot blot analysis on a Hybond N+membrane followed by
detection with an anti-dsDNA antibody. For TOP1ccs, samples were digested with
Benzonase for 30 min at 37 °C and analysed by slot blotting on a Nitrocellulose
membrane.
Colony forming assay. HeLa cells were seeded in triplicate on six-well plates and
allowed to attach for 16 h. Cells were then treated with the indicated doses of CPT
(Sigma-Aldrich) for 24 h, after which they were washed with PBS, and cultured in
DMEM complete media. Colonies were ﬁxed and stained 7–10 days later and the
number of colonies was counted using the automated colony counter, GelCount™
(DTI-Biotech). The number of colonies in treated samples is expressed as a per-
centage of the number of colonies in the untreated samples. Where indicated, cells
were transfected with siRNA and plasmid DNA (2 µg DNA; FuGENE HD) 72 and
48 h, respectively, before CPT treatment.
Alkaline comet assay. Cells were trypsinised, inactivated in 1% FBS-PBS,
resuspended in 1% low melting point agarose in PBS (37 °C), and embedded on
microscope slides pre-coated with 1% normal melting point agarose in dH2O.
Cells were lysed for 1 h at 4 °C in a buffer containing 2.5 M NaCl, 100 mM EDTA,
10 mM Tris–HCl, 1% (v/v) DMSO and 1% (v/v) Triton X-100, at pH 10.5. Slides
were then incubated in 4 °C electrophoresis buffer (300 mM NaOH, 1 mM EDTA,
1% (v/v) DMSO, pH > 13) for 30 min to unwind DNA. Electrophoresis was per-
formed in the same buffer for 25 min at 25 V (300 mA). Cells were then neu-
tralised in 0.5 M Tris–HCl pH 8.1 and stained with SYBR Gold (1:10,000 in dH2O)
for 30 min. Microscopy and analysis were performed using the Nikon NiE
microscope and Andor Komet7.1 software. At least 100 cells were quantiﬁed per
condition. Data are shown as Olive tail moments, calculated as: (tail mean−head
mean)*Tail%DNA/100.
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SUMO-binding assay. ΔTEX264 HEK293 cells transiently expressing GFP-tagged
or FLAG-tagged TEX264 variants were lysed in a lysis buffer containing 50 mM
Tris, pH 7.4, 500 mM NaCl, 1 mM EDTA, and 3% Triton X-100. Samples were
sonicated using a Bioruptor Plus sonicator (30 s ON, 30 s OFF for three cycles),
then diluted (1:3 volume) in IP wash buffer (150 mM NaCl, 50 mM Tris–HCl;
0.5 mM EDTA) and incubated with anti-FLAG M2 agarose or GFP trap beads
(Chromotek) for 2 h. After capture, the beads were washed three times in IP wash
buffer and incubated with 1 μg of free SUMO1 or SUMO2 (Boston Biochem) for
90 min at 4 °C with rotation. After washing three times in IP wash buffer, the
samples were eluted in Laemmli buffer for 5 min at 95 °C.
Isolation of proteins on nascent DNA. iPOND was performed as described
previously66. Brieﬂy, HEK293 cells were incubated with 10 μM EdU. For Supple-
mentary Fig. 7F, EdU incubation times were 8 and 16 min for WT cells and
ΔTEX264 cells, respectively, to account for the reduced EdU incorporation rates in
ΔTEX264 cells. Where indicated, cells were treated with CPT (100 nM) for 1 h in
normal media which was then supplemented with 10 μM EdU for the ﬁnal 8 or
16 min. Chromatin was fragmented into 50–300 bp fragments by sonication with a
Bioruptor Plus sonicator (30 s ON, 30 s OFF for 50 cycles). Biotin-labelled EdU was
captured by incubating samples overnight with streptavidin-coupled agarose beads
(Merck Millipore).
DNA ﬁbre assay. HEK293 cells were incubated in media containing 30 µM CldU
(Sigma-Aldrich, C6891) for 30 min, washed 3× in 37 °C PBS, and then incubated
with media containing 250 µM of IdU (Sigma-Aldrich, 17125) for an additional
30 min. Cells were then treated with ice-cold PBS. Cells were lysed in 200 mM
Tris–HCl pH 7.4, 50 mM EDTA, and 0.5% SDS directly onto glass slides and then
ﬁxed with 3:1 methanol and acetic acid overnight at 4 °C. The next day, the DNA
ﬁbres were denatured with 2.5 M HCl, blocked with 2% BSA and stained with
antibodies that speciﬁcally recognise either CldU (Abcam, Ab6326, dilution 1:500)
or IdU (BD-347580, dilution 1:500). Anti-rat Cy3 (dilution 1:300, Jackson Immuno
Research, 712-116-153) and anti-mouse Alexa-488 (dilution 1:300, Molecular
Probes, A11001) were used as the respective secondary antibodies. Microscopy was
performed using a Nikon 90i microscope. The lengths of the IdU-labelled tracts
were measured using ImageJ software and converted into microns. Statistical
analysis was performed using GraphPad Prism software using one-way ANOVA.
Immunoﬂuorescence. Cells were seeded on glass coverslips in six-well plates. Cells
were ﬁxed in 4% formaldehyde for 15 min at room temperature. Fixed cells were
washed with 1× PBS and permeabilised in 0.5% Triton X-100 prepared in PBS for
15 min at 4 °C. After blocking in 5% BSA/PBS for 1 h at room temperature, cells
were incubated with primary antibodies diluted in 2.5% BSA PBS solution for 1 h at
room temperature. Coverslips were then washed three times in 1× PBS and
incubated with secondary antibodies and DAPI (1:500) for 1 h at room tempera-
ture. Coverslips were mounted onto slides using ProLong Gold antifade reagent
(Invitrogen) and imaged using a Nikon 90i microscope. For EdU staining, cells
were treated with EdU (10 μM) for 30 min before ﬁxing, and then stained using the
Click-iT Plus EdU Alexa Fluor 647 imaging kit (Invitrogen). Confocal microscopy
was performed using Andor Dragonﬂy 200 on a Nikon Ti-E microscope. Z-stacks
were taken at an interval of 0.1 µM across cells ﬁxed identically to normal
brightﬁeld microscopy. ClearView-GPU™ deconvolution was carried out on sam-
ples where stated. Images were imported via Bio-Formats (ImageJ plugin) and
analysis was carried out using ImageJ. Images displayed are single z-slices unless
otherwise stated.
Visualisation of TOP1ccs by immunoﬂuorescence was performed essentially as
previously described36. Brieﬂy, cells were ﬁxed in 4% formaldehyde for 15 min at
room temperature, then permeabilised in 0.5% Triton X-100 for 15 min at 4 °C.
Cells were then treated with 0.5% SDS for 5 min at room temperature and washed
ﬁve times in a buffer containing 0.1% Triton X-100 and 0.1% BSA diluted in PBS.
After blocking in 5% BSA/PBS for 1 h at room temperature, cells were incubated
with an anti-TOP1cc antibody (Merck) diluted 1:100 in 2.5% BSA/PBS. Following
staining with secondary antibodies and DAPI, coverslips were mounted onto slides
using ProLong Gold antifade reagent (Invitrogen) and imaged using a Nikon 90i
microscope. Where indicated, siRNA transfections were performed 72 h before
cells were ﬁxed. Plasmid transfections (1 µg plasmid DNA) were performed using
FuGENE HD Transfection Reagent (Promega) 24 h before cell ﬁxation.
In vitro TOP1cc repair assay. FlpIn T-REx HEK293 cells inducibly expressing
TDP1-targetting miRNAs were treated with 1 µg/mL doxycycline for 48 h to
deplete TDP1, then treated with 10 μM MG132 for 1 h and 14 μM CPT for 30 min
to generate stable TOP1ccs. Cells were lysed in a guanidine hydrochloride-based
lysis buffer (8 M guanidine hydrochloride, 30 mM Tris–HCl pH 7.5, 10 mM EDTA,
1% sarkosyl, pH adjusted to 7.5) and separated by CsCl-gradient fractionation at
room temperature for 24 h84. TOP1ccs fractions were pooled and precipitated with
ice cold 100% acetone at −80 °C for 30 min, washed with 70% ethanol, air dried,
and resuspended in dialysis buffer (50 mM HEPES–KOH pH 7.5, 50 mM NaCl,
10 mM MgCl2, 0.5 mM TCEP) supplemented with protease inhibitors. Samples
were dialysed using Slide-A-Lyzer cassettes in 100× dialysis volume overnight at
4 °C. Samples were sedimented by centrifugation at 15,000×g for 20 min to remove
aggregated proteins. Samples were incubated with recombinant BSA, p97, and/or
TEX264 (100 nM/reaction) in reaction buffer (50 mM HEPES pH 7.5, 50 mM
NaCl, 10 mM MgCl2, 0.5 mM TCEP, ATP, 0.1 mg/mL protease-free BSA) at 37 °C
for 30 min, before addition of the indicated concentrations of recombinant SPRTN
for 1 h. Samples were then slot blotted onto a nitrocellulose membrane, blocked
with Odyssey blocking buffer (LI-COR) at room temperature for 1 h, and probed
with a TOP1cc-speciﬁc antibody at 4 °C overnight. After 3× TBS-T wash, the
membrane was probed with IRDye 680RD goat anti-mouse secondary antibody
(LI-COR) at room temperature for 1 h. After 3× TBS-T wash, the membrane was
imaged using Odyssey Fc Imaging system (LI-COR).
Flow cytometry. Seventy-two hours after siRNA transfection, cells were incubated
with EdU (Thermo Fisher) at a ﬁnal concentration of 10 µM for 30 min. Cells were
collected, washed twice in 1× PBS, resuspended in 4% PFA and left for 15 min.
Cells were then washed in 1× PBS, resuspended in FACS buffer (0.25% Saponin,
1% FBS in 1× PBS) by vortexing, and incubated for 15 min. The Click reaction
carried out according to the manufacturer’s instructions using the Click-iT® EdU
Alexa Fluor® 647 imaging kit (Thermo Fisher). Cells were washed once in FACS
buffer before resuspension in 1% BSA (diluted in 1× PBS) containing 10 µg/µL
RNAse and 20 µg/mL Propidium Iodide and incubated for 30 min. Samples were
then run on the FACSCalibur (BD Biosciences) and analysed using FlowJo®.
Representative gating strategy is provided as Supplementary Fig. 8.
Site-directed mutagenesis. Site-directed mutagenesis was performed by PCR
using the AccuPrime™ Pfx DNA Polymerase (ThermoFisher Scientiﬁc) according
to the manufacturer’s instructions. For primer sequences, see Supplementary
Table 1. Plasmids sequences were veriﬁed by sequencing at Source BioScience,
Oxford, UK.
Plasmid and siRNA Transfections. Plasmid DNA transfections were performed
using polyethyleneimine (PEI) reagent, Lipofectamine 3000 (Thermo Fisher), or
FuGENE HD Transfection Reagent (Promega), following the manufacturer’s
instructions.
All siRNA transfections were carried out using Lipofectamine RNAiMAX
(Invitrogen), according to the manufacturer’s protocol and assayed after 72 h.
The siRNA sequences used in this study are listed in Supplementary Table 2.
Antibodies. The details of antibodies used in this study are provided in Supple-
mentary Table 3.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The mass spectrometry raw datasets are publicly available through the ProteomeXchange
Consortium via the PRIDE partner repository with the dataset identiﬁer PXD017239 and
10.6019/PXD017239. The mass spectrometry datasets are also available in the Source
Data ﬁle. Source data for Figs. 1–6 and Supplementary Figs. 1–7 are provided as a Source
Data ﬁle. All other data are available from the corresponding author upon reasonable
request.
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